Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy

Benjamin Brenner; Jacob Green; Hanna Rosenbaum; Yehudith Ben Arieh; Arnon Nagler; Ilana Tatarsky

doi:10.1159/000206163

Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy

Benjamin Brenner^*
, Jacob Green
, Hanna Rosenbaum
, Yehudith Ben Arieh
, Arnon Nagler
, Ilana Tatarsky

^*Corresponding author for this work

Technion-Israel Institute of Technology

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

A patient with angioimmunoblastic lymphadenopathy (AILD) is presented. Manifestations of the disease appeared after short-term treatment with oxprenolol hydrochloride. Following treatment with prednisone, the patient remained in remission for 25 months. The disease relapsed following reuse of oxprenolol hydrochloride. Severe pancytopenia due to bone marrow involvement by AILD and myelofibrosis led to a fatal outcome. The association of AILD and myelofibrosis has been rarely encountered and is hereby discussed. In addition, the possible relationship between AILD and oxprenolol hydrochloride is considered.

Original language	English
Pages (from-to)	43-44
Number of pages	2
Journal	Acta Haematologica
Volume	74
Issue number	1
DOIs	https://doi.org/10.1159/000206163
State	Published - 1985
Externally published	Yes

Keywords

Angioimmunoblastic lymphadenopathy
Marrow fibrosis
Oxprenolol hydrochloride

Access to Document

10.1159/000206163

Cite this

@article{cf715aad5e1f424bbbda463a37f3fd01,

title = "Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy",

abstract = "A patient with angioimmunoblastic lymphadenopathy (AILD) is presented. Manifestations of the disease appeared after short-term treatment with oxprenolol hydrochloride. Following treatment with prednisone, the patient remained in remission for 25 months. The disease relapsed following reuse of oxprenolol hydrochloride. Severe pancytopenia due to bone marrow involvement by AILD and myelofibrosis led to a fatal outcome. The association of AILD and myelofibrosis has been rarely encountered and is hereby discussed. In addition, the possible relationship between AILD and oxprenolol hydrochloride is considered.",

keywords = "Angioimmunoblastic lymphadenopathy, Marrow fibrosis, Oxprenolol hydrochloride",

author = "Benjamin Brenner and Jacob Green and Hanna Rosenbaum and Arieh, \{Yehudith Ben\} and Arnon Nagler and Ilana Tatarsky",

year = "1985",

doi = "10.1159/000206163",

language = "אנגלית",

volume = "74",

pages = "43--44",

journal = "Acta Haematologica",

issn = "0001-5792",

publisher = "S. Karger AG",

number = "1",

}

TY - JOUR

T1 - Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy

AU - Brenner, Benjamin

AU - Green, Jacob

AU - Rosenbaum, Hanna

AU - Arieh, Yehudith Ben

AU - Nagler, Arnon

AU - Tatarsky, Ilana

PY - 1985

Y1 - 1985

N2 - A patient with angioimmunoblastic lymphadenopathy (AILD) is presented. Manifestations of the disease appeared after short-term treatment with oxprenolol hydrochloride. Following treatment with prednisone, the patient remained in remission for 25 months. The disease relapsed following reuse of oxprenolol hydrochloride. Severe pancytopenia due to bone marrow involvement by AILD and myelofibrosis led to a fatal outcome. The association of AILD and myelofibrosis has been rarely encountered and is hereby discussed. In addition, the possible relationship between AILD and oxprenolol hydrochloride is considered.

AB - A patient with angioimmunoblastic lymphadenopathy (AILD) is presented. Manifestations of the disease appeared after short-term treatment with oxprenolol hydrochloride. Following treatment with prednisone, the patient remained in remission for 25 months. The disease relapsed following reuse of oxprenolol hydrochloride. Severe pancytopenia due to bone marrow involvement by AILD and myelofibrosis led to a fatal outcome. The association of AILD and myelofibrosis has been rarely encountered and is hereby discussed. In addition, the possible relationship between AILD and oxprenolol hydrochloride is considered.

KW - Angioimmunoblastic lymphadenopathy

KW - Marrow fibrosis

KW - Oxprenolol hydrochloride

UR - https://www.scopus.com/pages/publications/0022376460

U2 - 10.1159/000206163

DO - 10.1159/000206163

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 3934907

AN - SCOPUS:0022376460

SN - 0001-5792

VL - 74

SP - 43

EP - 44

JO - Acta Haematologica

JF - Acta Haematologica

IS - 1

ER -

Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this